Trials / Sponsors / Elgan Pharma Ltd.
Elgan Pharma Ltd.
Industry · 5 registered clinical trials — 2 currently recruiting.
| Status | Trial | Phase | Started |
|---|---|---|---|
| Recruiting | Assess the Safety of ELGN-2112 in Preterm Infants Born Under 26 Weeks GA and IUGR Infants Born 26-32 Weeks GA Intestinal Malabsorption | Phase 2 | 2025-10-28 |
| Recruiting | Efficacy and Safety of ELGN-2112 on Intestinal Malabsorption in Preterm Infants Intestinal Malabsorption | Phase 3 | 2025-02-27 |
| Terminated | Safety and Efficacy Study in Infant With SBS Short Bowel Syndrome | Phase 2 / Phase 3 | 2017-03-20 |
| Terminated | Study to Assess the Efficacy and Safety of NTRA-2112 on Intestinal Malabsorption in Preterm Infants Premature Birth of Newborn, Intestinal Malabsorption | Phase 3 | 2016-10-09 |
| Terminated | Oral Formulation of Insulin for Preterm Infants Premature Birth of Newborn | Phase 2 | 2010-08-01 |